Luciana Batista
Innate Pharma (France)(FR)
Publications by Year
Research Areas
Immune Cell Function and Interaction, COVID-19 Clinical Research Studies, Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation, Cancer-related molecular mechanisms research
Most-Cited Works
- → Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis(2020)539 cited
- → miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response(2011)497 cited
- → Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression(2021)92 cited
- → Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer(2020)74 cited
- → Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19(2020)74 cited
- → Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant(2022)68 cited
- → Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through(2016)38 cited
- → Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE])*(2022)26 cited
- → 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis(2020)17 cited
- Manuseio da doença renal crônica em pacientes com hipertensão e diabetes(2005)